Variant report

Variant	esv3324763
Chromosome Location	chr20:23674755-23737044
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr20:23710603-23710866	H1-hESC	embryonic stem cell:	n/a	chr20:23710701-23710712
2	CEBPB	chr20:23687994-23688164	IMR90	lung:	n/a	chr20:23688059-23688070
3	CEBPB	chr20:23710550-23710870	IMR90	lung:	n/a	chr20:23710701-23710712
4	CEBPB	chr20:23715136-23715338	IMR90	lung:	n/a	chr20:23715271-23715282
5	CEBPB	chr20:23715133-23715386	HepG2	liver:	n/a	chr20:23715271-23715282
6	CEBPB	chr20:23684500-23684595	A549	lung:	n/a	chr20:23684504-23684515 chr20:23684504-23684517 chr20:23684506-23684515 chr20:23684506-23684515 chr20:23684506-23684515 chr20:23684506-23684517 chr20:23684506-23684515
7	CEBPB	chr20:23710539-23710875	A549	lung:	n/a	chr20:23710701-23710712
8	CEBPB	chr20:23710540-23710875	HepG2	liver:	n/a	chr20:23710701-23710712
9	CEBPB	chr20:23687946-23688194	A549	lung:	n/a	chr20:23688059-23688070
10	CEBPB	chr20:23684405-23684588	HepG2	liver:	n/a	chr20:23684504-23684515 chr20:23684504-23684517 chr20:23684506-23684515 chr20:23684506-23684515 chr20:23684506-23684515 chr20:23684506-23684517 chr20:23684506-23684515
11	CEBPB	chr20:23687909-23688202	HepG2	liver:	n/a	chr20:23688059-23688070
12	CEBPB	chr20:23710656-23710785	K562	blood:	n/a	chr20:23710701-23710712
13	CEBPB	chr20:23715126-23715326	A549	lung:	n/a	chr20:23715271-23715282
14	CTCF	chr20:23704460-23704610	GM12866	blood:	n/a	chr20:23704495-23704516 chr20:23704493-23704511 chr20:23704496-23704505
15	CTCF	chr20:23704380-23704530	HA-sp	spinal cord:	n/a	chr20:23704495-23704516 chr20:23704493-23704511 chr20:23704496-23704505
16	CTCF	chr20:23704420-23704570	HRPEpiC	eye:	n/a	chr20:23704495-23704516 chr20:23704493-23704511 chr20:23704496-23704505
17	CTCF	chr20:23729620-23729770	GM12864	blood:	n/a	n/a
18	CTCF	chr20:23704360-23704510	HEEpiC	esophagus:	n/a	chr20:23704496-23704505
19	CTCF	chr20:23704280-23704430	RPTEC	kidney:	n/a	n/a
20	CTCF	chr20:23704820-23704970	Caco-2	colon:	n/a	n/a
21	CTCF	chr20:23717740-23717890	MCF-7	breast:	n/a	n/a
22	CTCF	chr20:23729517-23729596	H1-hESC	embryonic stem cell:	n/a	n/a
23	CTCF	chr20:23686920-23686977	GM10266	blood:	n/a	n/a
24	CTCF	chr20:23704394-23704602	GM13976	blood:	n/a	chr20:23704495-23704516 chr20:23704493-23704511 chr20:23704496-23704505
25	CTCF	chr20:23704339-23704616	HepG2	liver:	n/a	chr20:23704495-23704516 chr20:23704493-23704511 chr20:23704496-23704505
26	CTCF	chr20:23704640-23704790	MCF-7	breast:	n/a	chr20:23704741-23704757 chr20:23704742-23704763 chr20:23704740-23704758
27	CTCF	chr20:23732332-23732473	K562	blood:	n/a	n/a
28	CTCF	chr20:23704354-23704855	NHEK	skin:	n/a	chr20:23704495-23704516 chr20:23704493-23704511 chr20:23704741-23704757 chr20:23704742-23704763 chr20:23704496-23704505 chr20:23704787-23704796 chr20:23704740-23704758
29	CTCF	chr20:23704900-23705050	HepG2	liver:	n/a	n/a
30	CTCF	chr20:23704380-23704530	HFF-Myc	foreskin:	n/a	chr20:23704495-23704516 chr20:23704493-23704511 chr20:23704496-23704505
31	CTCF	chr20:23704355-23704882	A549	lung:	n/a	chr20:23704495-23704516 chr20:23704493-23704511 chr20:23704741-23704757 chr20:23704742-23704763 chr20:23704496-23704505 chr20:23704787-23704796 chr20:23704740-23704758
32	CTCF	chr20:23704380-23704530	RPTEC	kidney:	n/a	chr20:23704495-23704516 chr20:23704493-23704511 chr20:23704496-23704505
33	CTCF	chr20:23705710-23705792	GM19239	blood:	n/a	n/a
34	CTCF	chr20:23704356-23704848	GM10266	blood:	n/a	chr20:23704495-23704516 chr20:23704493-23704511 chr20:23704741-23704757 chr20:23704742-23704763 chr20:23704496-23704505 chr20:23704787-23704796 chr20:23704740-23704758
35	CTCF	chr20:23704384-23704664	GM10248	blood:	n/a	chr20:23704495-23704516 chr20:23704493-23704511 chr20:23704496-23704505
36	CTCF	chr20:23704340-23704490	AG09309	skin:	n/a	n/a
37	CTCF	chr20:23704420-23704570	WERI-Rb-1	eye:	n/a	chr20:23704495-23704516 chr20:23704493-23704511 chr20:23704496-23704505
38	CTCF	chr20:23704380-23704530	GM12868	blood:	n/a	chr20:23704495-23704516 chr20:23704493-23704511 chr20:23704496-23704505
39	CTCF	chr20:23704060-23704210	MCF-7	breast:	n/a	n/a
40	CTCF	chr20:23704351-23704881	H1-hESC	embryonic stem cell:	n/a	chr20:23704495-23704516 chr20:23704493-23704511 chr20:23704741-23704757 chr20:23704742-23704763 chr20:23704496-23704505 chr20:23704787-23704796 chr20:23704740-23704758
41	CTCF	chr20:23704122-23704692	SK-N-SH	brain:	n/a	chr20:23704495-23704516 chr20:23704493-23704511 chr20:23704496-23704505
42	CTCF	chr20:23704380-23704530	HCT-116	colon:	n/a	chr20:23704495-23704516 chr20:23704493-23704511 chr20:23704496-23704505
43	CTCF	chr20:23704940-23705090	HAc	cerebellar:	n/a	n/a
44	CTCF	chr20:23713982-23714020	LNCaP	prostate:	n/a	n/a
45	CTCF	chr20:23735680-23735830	HCPEpiC	choroid plexus:	n/a	n/a
46	CTCF	chr20:23704340-23704490	NHEK	skin:	n/a	n/a
47	CTCF	chr20:23677891-23677951	GM20000	blood:	n/a	n/a
48	CTCF	chr20:23704280-23704430	NHDF-neo	bronchial:	n/a	n/a
49	CTCF	chr20:23704340-23704490	HMEC	breast:	n/a	n/a
50	CTCF	chr20:23729687-23729765	Pancreas_OC	pancreas:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr20:23732873-23732923	HRCEpiC	kidney:	n/a
2	chr20:23728432-23728482	BE2_C	brain:	n/a
3	chr20:23728432-23728482	HNPCEpiC	eye:	n/a
4	chr20:23728814-23728864	ProgFib	skin:	n/a
5	chr20:23732873-23732923	GM12891	blood:	n/a
6	chr20:23731367-23731417	IMR90	lung:	fetal
7	chr20:23732595-23732645	GM12892	blood:	n/a
8	chr20:23731367-23731417	GM06990	blood:	n/a
9	chr20:23728814-23728864	SKMC	muscle:	n/a
10	chr20:23728814-23728864	PrEC	prostate:	n/a
11	chr20:23732595-23732645	ovcar-3	ovarian:	n/a
12	chr20:23728814-23728864	AG04450	lung:	fetal
13	chr20:23732595-23732645	NH-A	brain:	n/a
14	chr20:23731367-23731417	BE2_C	brain:	n/a
15	chr20:23728432-23728482	SKMC	muscle:	n/a
16	chr20:23732595-23732645	Caco-2	colon:	n/a
17	chr20:23732873-23732923	H1-hESC	embryonic stem cell:	embryo
18	chr20:23728814-23728864	HCT-116	colon:	n/a
19	chr20:23732595-23732645	NB4	blood:	n/a
20	chr20:23728814-23728864	HUVEC	blood vessel:	n/a
21	chr20:23728814-23728864	GM19239	blood:	n/a
22	chr20:23732595-23732645	RPTEC	kidney:	n/a
23	chr20:23732873-23732923	CMK	blood:	n/a
24	chr20:23728432-23728482	AG04450	lung:	fetal
25	chr20:23732595-23732645	PFSK-1	brain:	n/a
26	chr20:23732595-23732645	AoSMC	blood vessel:	n/a
27	chr20:23731367-23731417	Jurkat	blood:	n/a
28	chr20:23728432-23728482	ovcar-3	ovarian:	n/a
29	chr20:23732873-23732923	A549	lung:	n/a
30	chr20:23728814-23728864	Caco-2	colon:	n/a
31	chr20:23732595-23732645	AG04450	lung:	fetal
32	chr20:23728814-23728864	HRCEpiC	kidney:	n/a
33	chr20:23731367-23731417	PrEC	prostate:	n/a
34	chr20:23732873-23732923	IMR90	lung:	fetal
35	chr20:23731367-23731417	AG10803	skin:	n/a
36	chr20:23728432-23728482	AoSMC	blood vessel:	n/a
37	chr20:23728814-23728864	SAEC	small airway:	n/a
38	chr20:23728432-23728482	ECC-1	luminal epithelium:	n/a
39	chr20:23732595-23732645	HAEpiC	amniotic membrane:	n/a
40	chr20:23728814-23728864	HMEC	breast:	n/a
41	chr20:23732595-23732645	SK-N-SH	brain:	n/a
42	chr20:23732873-23732923	Jurkat	blood:	n/a
43	chr20:23732595-23732645	IMR90	lung:	fetal
44	chr20:23728432-23728482	U87	brain:	n/a
45	chr20:23731367-23731417	HRCEpiC	kidney:	n/a
46	chr20:23732595-23732645	AG09309	skin:	n/a
47	chr20:23728432-23728482	AG04449	skin:	fetal
48	chr20:23728432-23728482	Jurkat	blood:	n/a
49	chr20:23728814-23728864	A549	lung:	n/a
50	chr20:23728814-23728864	HL-60	blood:	n/a

No.	Distal block	Cell Line	Cell type
1	chr20:23704352..23705295-chr20:23754423..23755304,4	MCF-7	breast:
2	chr20:23648920..23650143-chr20:23704363..23705222,5	MCF-7	breast:
3	chr20:23648334..23649447-chr20:23704109..23705001,3	MCF-7	breast:
4	chr20:23704490..23705249-chr20:23762654..23763235,2	MCF-7	breast:
5	chr20:23648954..23649672-chr20:23703387..23704074,2	MCF-7	breast:
6	chr20:23702805..23703439-chr20:23754485..23755364,2	MCF-7	breast:
7	chr20:23704491..23705478-chr20:23779622..23780975,4	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CST8-5	chr20:23732376-23732473	NONHSAT079083
2	lnc-CST8-5	chr20:23726778-23726924	NONHSAT079083
3	lnc-CST8-5	chr20:23733160-23733281	NONHSAT079083
4	lnc-CST8-5	chr20:23733871-23734300	NONHSAT079083

Variant related genes	Relation type
CST1	TF binding region
CST2P1	TF binding region
CST1	CpG island
CST2P1	CpG island

Extended variants
information (count: 2102 )
Associated
traits (count: 61 )

Variant overlapped rSNPs/rCNVs (count:2102 , 50 per page) page: 1 2 3 4 5 6 7 ... 43

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs529847241	chr20:23674755-23674756	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs116496865	chr20:23674763-23674764	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs140562274	chr20:23674781-23674782	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs538221401	chr20:23674813-23674814	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs191207446	chr20:23674820-23674821	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs6138040	chr20:23674825-23674826	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs564747084	chr20:23674846-23674847	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs149747746	chr20:23674859-23674860	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs574670772	chr20:23674870-23674871	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs8119415	chr20:23674876-23674877	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs183373808	chr20:23674878-23674879	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs73104345	chr20:23674885-23674886	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs545835193	chr20:23674899-23674900	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs562901575	chr20:23674906-23674907	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs117397616	chr20:23674907-23674908	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs544505515	chr20:23674923-23674924	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs561096715	chr20:23674926-23674927	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs377248032	chr20:23674930-23674931	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs546733859	chr20:23674950-23674951	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs529584912	chr20:23674969-23674970	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs566405196	chr20:23674980-23674981	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs548225790	chr20:23674983-23674984	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs187622281	chr20:23675016-23675017	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs8120766	chr20:23675043-23675044	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs113213905	chr20:23675076-23675077	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs370713484	chr20:23675077-23675078	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs200967430	chr20:23675079-23675080	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs34610342	chr20:23675082-23675083	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs538175222	chr20:23675096-23675097	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs551985260	chr20:23675126-23675127	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs145691169	chr20:23675151-23675152	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs568330462	chr20:23675157-23675158	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs528271431	chr20:23675161-23675162	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs554239962	chr20:23675196-23675197	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs185101351	chr20:23675197-23675198	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs546273026	chr20:23675221-23675222	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs556319610	chr20:23675241-23675242	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs373218522	chr20:23675243-23675244	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs189983007	chr20:23675250-23675251	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs544540707	chr20:23675278-23675279	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs561134056	chr20:23675302-23675303	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs574695415	chr20:23675331-23675332	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs540008158	chr20:23675339-23675340	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs560292026	chr20:23675344-23675345	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs192994811	chr20:23675359-23675360	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs184690798	chr20:23675421-23675422	Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs188395161	chr20:23675422-23675423	Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs148934359	chr20:23675453-23675454	Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs375083256	chr20:23675464-23675465	Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs180764268	chr20:23675489-23675490	Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:61)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	16272173	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	19627613	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Colorectal cancer	19359472	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Central neurocytomas	17123091	CNVD
Colorectal cancer	16272173	CNVD
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Colorectal cancer	21645411	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Autism	22495311	CNVD
Renal cell carcinoma	18765545	CNVD
Alagille syndrome	17576883	CNVD
Anaplastic large cell lymphoma	18179710	CNVD
Prostate cancer	18632612	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Cancer	21183584	CNVD
Myxofibrosarcoma	16751306	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Breast cancer	16608533	CNVD
Bladder cancer	21909424	CNVD
Esophageal cancer	21851588	CNVD
Breast cancer	17133270	CNVD
Thrombophilia	17576883	CNVD
Myelofibrosis	22110671	CNVD
Mental retardation	21062444	CNVD
Hepatocellular carcinoma	22174799	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Chordoma	18071362	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
small cell lung cancer	17426248	CNVD
Breast cancer	21364760	CNVD
Gastric cancer	22014070	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:148 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr20:23671200-23675000	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
2	chr20:23671400-23676000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
3	chr20:23672000-23674800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
4	chr20:23672000-23675800	Enhancers	HUVEC	blood vessel
5	chr20:23672200-23675800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
6	chr20:23672600-23675000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
7	chr20:23673200-23675000	Enhancers	Left Ventricle	heart
8	chr20:23673200-23676400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
9	chr20:23673400-23675800	Enhancers	HUES6 Cell Line	embryonic stem cell
10	chr20:23673400-23676000	Enhancers	ES-I3 Cell Line	embryonic stem cell
11	chr20:23673600-23674800	Weak transcription	Lung	lung
12	chr20:23674000-23676400	Enhancers	HUES64 Cell Line	embryonic stem cell
13	chr20:23674200-23675000	Weak transcription	H1 Cell Line	embryonic stem cell
14	chr20:23674200-23675200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
15	chr20:23674400-23675000	Bivalent Enhancer	HepG2	liver
16	chr20:23674400-23675400	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
17	chr20:23674400-23675400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
18	chr20:23674600-23675600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
19	chr20:23674600-23676000	Enhancers	iPS-20b Cell Line	embryonic stem cell
20	chr20:23674800-23675000	Enhancers	Lung	lung
21	chr20:23674800-23675200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
22	chr20:23674800-23675800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
23	chr20:23674800-23675800	Enhancers	H9 Cell Line	embryonic stem cell
24	chr20:23675000-23675800	Enhancers	H1 Cell Line	embryonic stem cell
25	chr20:23675000-23675800	Enhancers	HepG2	liver
26	chr20:23675000-23676400	Enhancers	iPS-18 Cell Line	embryonic stem cell
27	chr20:23675200-23675600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
28	chr20:23675200-23675800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
29	chr20:23675200-23676000	Enhancers	iPS-15b Cell Line	embryonic stem cell
30	chr20:23675200-23676400	Enhancers	HUES48 Cell Line	embryonic stem cell
31	chr20:23675400-23675800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
32	chr20:23675400-23675800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
33	chr20:23675600-23675800	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
34	chr20:23675800-23677800	Weak transcription	HUES6 Cell Line	embryonic stem cell
35	chr20:23675800-23681600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
36	chr20:23676400-23679200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
37	chr20:23677800-23678600	Enhancers	HUES6 Cell Line	embryonic stem cell
38	chr20:23678000-23678200	Enhancers	GM12878-XiMat	blood
39	chr20:23679200-23680600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
40	chr20:23679800-23680000	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
41	chr20:23680000-23681800	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
42	chr20:23681200-23681400	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
43	chr20:23681400-23682800	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
44	chr20:23681600-23682200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
45	chr20:23681800-23683000	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
46	chr20:23682200-23684800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
47	chr20:23682400-23683000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
48	chr20:23682800-23684000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
49	chr20:23684800-23685000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
50	chr20:23694000-23694400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links